JPMORGAN CHASE & CO - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 257 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$6,330,870
-21.6%
165,773
-15.6%
0.00%0.0%
Q2 2023$8,073,944
-25.1%
196,303
+4.6%
0.00%0.0%
Q1 2023$10,776,000
+113451.1%
187,701
+10.9%
0.00%0.0%
Q4 2022$9,490
-99.9%
169,249
-16.2%
0.00%0.0%
Q3 2022$8,554,000
-11.7%
201,952
+12.7%
0.00%0.0%
Q2 2022$9,684,000
-2.6%
179,224
+15.9%
0.00%0.0%
Q1 2022$9,940,000
-9.1%
154,682
-5.2%
0.00%0.0%
Q4 2021$10,934,000
+12.1%
163,219
+14.6%
0.00%0.0%
Q3 2021$9,754,000
-7.5%
142,430
-7.9%
0.00%0.0%
Q2 2021$10,549,000
+9.5%
154,580
+10.8%
0.00%0.0%
Q1 2021$9,635,000
+21.8%
139,461
+14.4%
0.00%0.0%
Q4 2020$7,913,000
+38.4%
121,875
-1.1%
0.00%0.0%
Q3 2020$5,718,000
+6.5%
123,173
+7.8%
0.00%0.0%
Q2 2020$5,371,000
-31.6%
114,294
-35.0%
0.00%
-50.0%
Q1 2020$7,856,000
-23.3%
175,868
+0.0%
0.00%0.0%
Q4 2019$10,245,000
-8.8%
175,788
-6.0%
0.00%0.0%
Q3 2019$11,237,000
+47.0%
187,086
+33.0%
0.00%
+100.0%
Q2 2019$7,646,000
-15.9%
140,648
-13.8%
0.00%
-50.0%
Q1 2019$9,088,000
+111.5%
163,093
+71.2%
0.00%
+100.0%
Q4 2018$4,296,000
-76.5%
95,251
-65.6%
0.00%
-66.7%
Q3 2018$18,251,000
+108.8%
277,064
+104.2%
0.00%
+50.0%
Q2 2018$8,741,000
+903.6%
135,696
+761.5%
0.00%
Q1 2018$871,000
-59.8%
15,751
-65.2%
0.00%
Q4 2017$2,165,000
+3508.3%
45,221
+3681.0%
0.00%
Q3 2017$60,000
-39.4%
1,196
-34.4%
0.00%
Q2 2017$99,000
-98.1%
1,824
-98.5%
0.00%
-100.0%
Q1 2017$5,180,000
-26.7%
122,968
+49.3%
0.00%
-50.0%
Q4 2016$7,066,000
+353200.0%
82,364
+374281.8%
0.00%
Q3 2016$2,000
-99.9%
22
-99.9%
0.00%
-100.0%
Q2 2016$2,040,000
+56.2%
25,567
+31.8%
0.00%
Q1 2016$1,306,000
+5.6%
19,397
+6.3%
0.00%
Q4 2015$1,237,000
+29.4%
18,248
+13.7%
0.00%
Q3 2015$956,000
+14.6%
16,043
+29.6%
0.00%
Q2 2015$834,000
+9.6%
12,383
+0.4%
0.00%
Q1 2015$761,000
+214.5%
12,337
+177.0%
0.00%
Q4 2014$242,000
-53.3%
4,453
-59.0%
0.00%
Q4 2013$518,000
-69.4%
10,850
-74.2%
0.00%
-100.0%
Q3 2013$1,692,000
+15.2%
42,034
+4.9%
0.00%
Q2 2013$1,469,00040,0860.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q3 2023
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders